More than two-thirds of patients with hepatitis C who visited a Federally Qualified Health Center in Philadelphia were linked to care, including both antibody and RNA testing, and many continued to medical evaluation, according to a study published in Hepatology.
“Scaling up treatment services in settings where HCV testing is offered may help to improve the HCV care continuum,” Catelyn Coyle, MPH, MEd, from the Johns Hopkins Bloomberg School of Public Health, and colleagues wrote. “Expanding the capacity of primary care providers to treat is feasible given the simplicity of treatment and the availability of supportive resources during training and treatment.”
Between Oct. 1, 2012, and June 30, 2016, a total of 25,853 patients with HCV visited one of the five Federally Qualified Health Centers (FQHCs) in Philadelphia that are a run by the National Nurse-Led Care Consortium’s Public Health Management Corporation (PHMC).
Share This Page